Showing results (391-400 of 1,349) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|September 15, 2016
Effects of Age, Sex, and Obesity on the Single-Dose Pharmacokinetics of Omarigliptin in Healthy SubjectsCarol Addy, Daniel A Tatosian, Xiaoli S Glasgow, et al.
Clinical Pharmacology in Drug Development|April 17, 2018
Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers: A Randomized, Single-Dose, Two-Period, Two-Sequence Crossover StudyJiangying Chen, Jialang Zhuang, Jingguo Wu, et al.
Clinical Pharmacology in Drug Development|April 27, 2017
The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug FormulationMagnus N Hattrem, Morten J Dille, Tore Seternes, et al.
Clinical Pharmacology in Drug Development|August 23, 2016
Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor AlectinibPeter N Morcos, Yumi Cleary, Elena Guerini, et al.
Clinical Pharmacology in Drug Development|June 15, 2018
Pharmacokinetics of Co-Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed-Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single-Dose, Crossover Study in Healthy AdultsAndrea Maes, Paolo DePetrillo, Shahid Siddiqui, et al.
Clinical Pharmacology in Drug Development|April 10, 2023
Pharmacokinetics and Bioequivalence of Fluconazole Capsules Manufactured in France and China in Healthy Chinese Participants: Open-Label, Randomized, Single-Dose, 2-Way, Crossover Bioequivalence Study Under Fasted and Fed ConditionsNaihan Chen, Qing He, Ying Ma, et al.
Clinical Pharmacology in Drug Development|March 31, 2021
Results of a Dose-Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerEnriqueta Felip, Mauricio Burotto, Zanete Zvirbule, et al.
Clinical Pharmacology in Drug Development|March 31, 2021
Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal DiseaseSudhakar M Pai, Hiroyuki Yamada
Clinical Pharmacology in Drug Development|March 31, 2021
The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation DisordersSun Ku Lee, Manju Gupta, Jack Shi, et al.
Clinical Pharmacology in Drug Development|April 6, 2023
Bioequivalence Study of Ezetimibe Tablets After a Single Oral Dose of 10 mg in Healthy Japanese Subjects Under Fasting ConditionsShigenori Wada, Yoshiyuki Sasagane, Seiya Kagatani, et al.
Pageof 135